.png)
Agenzia Italiana del Farmaco
home
Highlights
-
18 Sep 2025
Press releases
The NHS will reimburse the first gene editing therapy for β-thalassemia and sickle cell anaemia
The AIFA Board of Directors approves the reimbursement of 7 new medicinal products (including 2 orphans), 6 generic medicines and 6 extensions of therapeutic indications.
-
12 Sep 2025
Press releases
“Medicines are not sweets”. A European campaign to promote the responsible use of over-the-counter medicines
Read the leaflet, follow the instructions, and use (over-the-counter) medicines responsibly. This is the core message shared of a European-wide awareness campaign launched by regulatory authorities to encourage the responsible use of over-the-counter (OTC) medicines.
-
11 Sep 2025
The Agency
European Project IncreaseNET: the market investigation for the provision of training courses on pharmaceutical innovation will close on 22 September
The IncreaseNET project, funded under the European program - Joint Action EU4Health 2021-2027, involves 29 partners, mainly National Competent Authorities in the pharmaceutical sector.
-
10 Sep 2025
Press releases
AIFA launches the second Independent Research Call for year 2025
Focus on precision medicine and fight against antimicrobial resistance, with a EUR 20 million funding.
News
15 Sep 2025
Transparency Lists
AIFA aggiorna le Liste di Trasparenza
03 Sep 2025
The Agency
Interruption of the telephone switchboard service and the Farmaci-Line toll-free number
19 Sep 2025
Quality and Inspections
Important information on supply shortage of Visudyne (verteporfin)
17 Sep 2025
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 31 March 2025
16 Sep 2025
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) - Finasteride, dutasteride – New measures to minimise the risk of suicidal ideation
12 Sep 2025
Monitoring Registers
Hepatitis C: update of 8 September 2025 concerning enrolled patients
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
Media
